Iovance Biotherapeutics Inc
NASDAQ:IOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
US |
|
Billington Holdings PLC
LSE:BILN
|
UK |
|
Weebit Nano Ltd
ASX:WBT
|
AU |
|
Coeur Mining Inc
NYSE:CDE
|
US |
|
Givaudan SA
SIX:GIVN
|
CH |
|
K
|
Kronos Worldwide Inc
XMUN:K1W
|
US |
|
R
|
Rattanindia Enterprises Ltd
BSE:534597
|
IN |
|
P
|
Prolexus Bhd
KLSE:PRLEXUS
|
MY |
|
H
|
Hargreaves Services PLC
F:H6W
|
UK |
|
N
|
Navigator Global Investments Ltd
F:HVH
|
AU |
|
C
|
Clariant AG
XBER:CLRN
|
CH |
|
K
|
Kinaxis Inc
F:9KX
|
CA |
|
Reliance Worldwide Corporation Ltd
F:0EU
|
AU |
|
C
|
China Sunsine Chemical Holdings Ltd
SGX:QES
|
SG |
|
Credit Agricole SA
OTC:CRARF
|
FR |
|
B
|
B.P. Marsh & Partners PLC
XBER:B5V
|
UK |
|
R
|
Realtech AG
SWB:RTC
|
DE |
|
Cadre Holdings Inc
NYSE:CDRE
|
US |
|
X
|
Xtant Medical Holdings Inc
AMEX:XTNT
|
US |
|
Enseval Putera Megatrading Tbk PT
IDX:EPMT
|
ID |
|
Daxor Corp
NASDAQ:DXR
|
US |
Wall St Price Targets
IOVA Price Targets Summary
Iovance Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for
IOVA is 8.98 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IOVA's stock price target?
Price Target
8.98
USD
According to Wall Street analysts, the average 1-year price target for
IOVA is 8.98 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Revenue over the next 8 years is 29%.
What is the Gross Profit forecast for Iovance Biotherapeutics Inc?
Projected CAGR
43%
The compound annual growth rate for Gross Profit over the next 8 years is 43%.